Bivalirudin versus heparin in ST and non-ST-segment elevation myocardial infarction—Outcomes at two years
Elmir Ömerovic(Sahlgrenska University Hospital), David Erlinge(Lund University), Loghman Henareh(Karolinska University Hospital), Lotta Robertsson(Södra Älvsborg Hospital), Mehmet Hamid(Karolinska University Hospital), Helena Wikström(Örebro University Hospital), Dan Ioanes(Sahlgrenska University Hospital), Anders Ulvenstam(Östersunds Hospital), Jason Stewart(Örebro University Hospital), Rikard Linder(Karolinska University Hospital), Ole Fröbert(Aarhus University), Leszek Zagozdzon(Örebro University), Tim Tödt(Linköping University Hospital), Stefan James(Uppsala University), Mikael Danielewicz(Örebro University Hospital), Oskar Angerås(Sahlgrenska University Hospital), Jonas Andersson(Skellefteå Hospital), Claes Held(Uppsala University), Thomas Kellerth(Karolinska University Hospital), Pontus Lindros(Stockholm South General Hospital), Pallonji Bhiladval(Uppsala University), Truls Råmundal(Sahlgrenska University Hospital), Ollie Östlund(Karolinska University Hospital), Jens Jensen(Karolinska Institutet), Henrik Wagner(Örebro University Hospital), Matthias Götberg, Sasha Koul(Lund University), Christos Pagonis
Cited by 4
Related Papers
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
|New England Journal of Medicine|2009|7.1k
ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
|European Heart Journal|2012|6.8k
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k
2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS
|European Heart Journal|2017|3k
Targeted Temperature Management at 33°C versus 36°C after Cardiac Arrest
|New England Journal of Medicine|2013|2.8k